USC Dornsife News

Mutant Cells Dig in Their Heels

Tue, 20 Nov 2012 16:00:00 -0500

Combining genetic tools, drug treatment and state-of-the-art imaging, USC Dornsife’s Susan Forsburg and her researchers have found that some cancer cells continue to replicate even after treatment.

Hope Against Ovarian Cancer

Thu, 11 Oct 2012 15:45:00 -0500

A recently published study co-authored by USC Dornsife’s Nicos Petasis reveals a new drug that may be an effective alternative for cancer patients resistant to currently available drugs.

Fasting and Radiation Therapy

Mon, 1 Oct 2012 16:00:00 -0500

PLOS One shows that short-term fasting in mice appears to improve the effectiveness of radiation and chemotherapy in treating gliomas. Here Longo works in his laboratory. Photo by Dietmar Quistorf." title="USC Dornsife's Valter Longo's latest study published in PLOS One shows that short-term fasting in mice appears to improve the effectiveness of radiation and chemotherapy in treating gliomas. Here Longo works in his laboratory. Photo by Dietmar Quistorf." /> A new study published in PLOS One and led by USC Dornsife’s Valter Longo finds that controlled short-term fasting in mice improved the effectiveness of radiation and chemotherapy in treating gliomas, the most commonly diagnosed brain tumor.

Risk and Reward

Fri, 8 Jun 2012 08:12:00 -0500

Matthew Pratt of chemistry and biological sciences in USC Dornsife has been named a 2012 Damon Runyon-Rachleff Innovator for discovering a link between metabolism and protein modification in cancer.